No, peptides are not steroids. Peptides are chains of amino acids joined by amide bonds, while steroids are lipids built on a four-ring carbon skeleton derived from cholesterol. The question of whether peptides are steroids arises because both classes include hormones, both are measured in anti-doping and endocrinology laboratories, and both are discussed in the same breath in popular media. Chemically and biologically, however, they are unrelated: they differ in structure, synthesis, receptors, speed of signalling and analytical behaviour. This article sets out those differences, the published research behind them, the laboratory contexts where each class is studied, and the handling requirements that follow.
Are peptides steroids? The chemical distinction
A peptide is a polymer. Amino acids, each with an amino group, a carboxyl group and a side chain, condense to form peptide bonds, and the sequence from the N-terminus to the C-terminus defines the molecule. The average residue contributes about 110 daltons, so a ten-residue peptide weighs a little over one kilodalton and a 30-residue peptide about three. Peptides are polar, usually water-soluble, and carry charges that depend on their side chains. By convention, chains of up to about fifty residues are called peptides, and longer chains proteins.
A steroid is a small lipid with a rigid tetracyclic core, three six-membered rings and one five-membered ring fused together. All steroids derive biosynthetically from cholesterol, which has 27 carbons and a mass near 387 daltons. Testosterone has a mass of about 288 daltons, estradiol about 272 and cortisol about 362. Steroid hormones differ from one another by the number and position of their double bonds, hydroxyl groups and ketone groups, rather than by any sequence. They are hydrophobic and cross cell membranes by diffusion.
The two classes also have different histories. Emil Fischer proposed the peptide-bond concept and coined “peptide” in 1902, Frederick Sanger sequenced insulin in the early 1950s, and Vincent du Vigneaud synthesised oxytocin in 1953. Steroid chemistry developed along a separate track: in 1935, Ernst Laqueur’s group isolated testosterone, and Adolf Butenandt and Leopold Ruzicka synthesised it, work for which the latter two shared the 1939 Nobel Prize in Chemistry. Peptide synthesis was transformed by Bruce Merrifield’s solid-phase method in 1963, while steroid production relies on organic synthesis and semi-synthesis from plant sterols.
The biosynthetic contrast is just as clear. Peptide hormones are encoded by genes, translated on ribosomes as larger precursors, cleaved by convertase enzymes and stored in secretory vesicles. Steroid hormones are made on demand, through a series of cytochrome P450 and dehydrogenase reactions in tissues such as the adrenal cortex and gonads, and are not stored in vesicles. These are different molecular classes with different origins.
Mechanism of action
The sharpest difference between the two classes lies in how they signal. Most peptides are hydrophilic and cannot cross the plasma membrane, so they act on receptors at the cell surface. The largest group of targets is the G protein-coupled receptor (GPCR) family. When a peptide binds a GPCR, the receptor changes shape and activates a G protein, which raises cyclic AMP through Gs, mobilises calcium through Gq and phospholipase C, or lowers cyclic AMP through Gi. Other peptides act through receptor tyrosine kinases, such as the insulin and IGF-1 receptors, which activate the PI3K and Akt cascade. These second-messenger systems operate within seconds to minutes, and signalling ends through proteolytic degradation of the peptide and receptor desensitisation.
Steroids take a different route. Being lipophilic, they diffuse through the membrane and bind receptors inside the cell, which belong to the nuclear receptor superfamily. Ligand binding causes the receptor to change shape, shed chaperone proteins and bind specific DNA sequences called hormone response elements, where it recruits co-activators or co-repressors and alters the transcription of target genes. This genomic route typically produces effects over hours, since new messenger RNA and protein must be made. Steroids also have faster, non-genomic actions at membrane-associated receptors, but the intracellular receptor pathway is the defining one.
Transport differs as well. Peptides circulate mostly free and are cleared within minutes by proteases and the kidney. Steroids travel bound to carrier proteins such as albumin and sex hormone-binding globulin, which extends their persistence and buffers the free fraction. In short, a peptide is a signal read at the surface, and a steroid is a signal that reaches the genome.
What the research shows
Four areas of published work illustrate the separation between the two classes. Readers should consult the primary papers for methods and data.
The first is Ronald Evans’s 1988 review in Science, which brought together the discovery of the steroid and thyroid hormone receptor superfamily. Steroid receptors were first identified through radioactively labelled ligands in the early 1970s, and they were present in only trace amounts, around a thousand to ten thousand per cell, so they had to be enriched by 100,000- to 1,000,000-fold to be purified. Each receptor undergoes a structural change on hormone binding that enables it to bind DNA. The cloning of the glucocorticoid receptor then revealed its relationship to a family of regulatory proteins. The article is open access on PubMed Central.
The second is the discovery of ghrelin by Kojima and colleagues, published in Nature in 1999, which illustrates the peptide side. The group purified an endogenous ligand for an orphan cell-surface receptor from rat stomach, a peptide of 28 amino acids in which serine 3 carries an n-octanoyl group. The acylated peptide released growth hormone in vivo and in vitro, and the octanoyl modification was essential for activity. The receptor is a GPCR on the cell surface, in contrast with the intracellular receptors in Evans’s review. The record is on PubMed.
The third is the synthesis of testosterone in 1935 by Butenandt and Ruzicka. By building a steroid hormone from cholesterol-derived starting materials, the work confirmed the four-ring structure of the molecule and began the era of synthetic steroid chemistry. It is a useful reminder that steroid synthesis is conducted with classical organic chemistry, quite unlike the stepwise amide coupling of peptide assembly. The original publications and historical reviews describe it in detail, so it is summarised here in general terms.
The fourth is Sanger’s determination of the insulin sequence, which showed that a protein has a defined, reproducible order of residues and therefore a defined mass. That principle underlies modern peptide identity testing, in which a measured mass is compared with the theoretical mass for the intended sequence. No equivalent “sequence” exists for steroids, whose identity rests on skeleton, functional groups and stereochemistry.
Research applications
Because the two classes act through different receptors, they are applied to different experimental questions, and sometimes combined.
In peptide research, cultured cells are used to study GPCR and tyrosine-kinase signalling, with readouts such as cyclic AMP accumulation, calcium flux, phospho-specific immunoblotting and quantitative PCR. Peptides also serve as enzyme substrates and inhibitors, immunological epitopes, structural models and analytical standards. In steroid research, nuclear receptor assays are used, including reporter-gene systems in which a hormone response element drives luciferase, as well as receptor-binding competition assays and studies of steroid metabolism by cytochrome P450 enzymes.
Combined designs examine cross-talk, for example how a cell-surface signal modifies the activity of a nuclear receptor, or how steroid exposure changes the expression of a peptide receptor. In analytical chemistry, both classes are measured by liquid chromatography and mass spectrometry, and anti-doping and forensic laboratories need well-characterised reference standards for each.
The regulatory position also differs, and purchasers should be aware of it. Anabolic steroids are Class C controlled drugs under the Misuse of Drugs Act 1971. Most research peptides are not scheduled, although some peptide hormones, such as somatropin, are controlled. Separately, the Medicines and Healthcare products Regulatory Agency decides case by case whether a product is a medicine, looking at labelling, packaging, promotional literature and advertisements, including websites. The agency’s borderline products guidance sets out its approach. This is general information rather than legal advice, and the current legislation should be checked for any specific compound.
Purity, storage and handling
The chemical difference between the classes has practical consequences at the bench. Many crystalline steroids are relatively robust solids, whereas peptides are sensitive to moisture, oxidation and, once dissolved, to hydrolysis and aggregation. Researchers who ask are peptides steroids in a procurement context should therefore treat peptides as biomolecules with their own quality requirements, expecting a batch-specific certificate of analysis and lyophilised storage at -20°C, and the practical checks for comparing suppliers are set out in How to buy best peptides.
Purity verification for peptides starts with reversed-phase HPLC, usually with UV detection at 214 or 220 nm, where the peptide bond absorbs. This separates the target from deletion sequences, truncated chains and incompletely deprotected by-products, and reports purity as the percentage of total peak area belonging to the target. A figure of 98% or higher is commonly specified for cell-based and receptor assays. HPLC does not prove identity, so it should be paired with mass spectrometry confirming that the observed mass matches the theoretical value. Steroids, which often lack a strong chromophore, are frequently confirmed by mass spectrometry or after derivatisation.
A batch-specific certificate of analysis matters because synthesis is never perfectly repeatable. Two lots of the same sequence can differ in purity, counter-ion content, water content and net peptide content, and a generic specification sheet cannot capture that variation. A proper certificate lists the lot number, chromatogram, mass-spectrometry result and analysis date, so a result can be traced to a specific vial.
Lyophilised peptides are most stable when kept dry, sealed and cold. Storage at -20°C is the usual recommendation for the long term, and -80°C is sometimes preferred for sensitive sequences. Vials should be brought to room temperature in a desiccator before opening, because condensation introduces moisture that promotes hydrolysis. Sequences rich in cysteine, methionine or tryptophan are prone to oxidation, while those containing asparagine or glutamine can deamidate over time.
Reconstituted peptides are far less stable than the dry powder. Stock solutions are normally prepared in sterile water or a suitable buffer, divided into single-use aliquots and frozen to avoid repeated freeze-thaw cycles. Stability in solution is sequence-specific, and researchers should consult supplier data and validate it under their own conditions. Light sensitivity is a further consideration, since peptides containing tryptophan or tyrosine, and those carrying fluorophore labels, can undergo photo-oxidation. Vials are best kept in the dark or in amber glass, and each aliquot should be labelled with the date, lot number and concentration.
Frequently asked questions
Is a peptide hormone the same as a steroid hormone?
No. Both are hormone classes, but they are chemically unrelated. Peptide hormones are amino acid chains that bind receptors on the cell surface, while steroid hormones are lipid-soluble molecules built on a four-ring carbon skeleton derived from cholesterol that bind receptors inside the cell. Sharing the word “hormone” does not mean sharing structure or mechanism.
Are peptides anabolic steroids?
No. Anabolic steroids are synthetic derivatives of testosterone that retain the four-ring steroid skeleton, and they are Class C controlled drugs in the UK. Peptides are amino acid chains with no steroid skeleton, and most research peptides are not scheduled, although some peptide hormones are. Check the current legislation for any specific compound.
How should peptides and steroids be stored differently in the laboratory?
Lyophilised peptides are kept sealed, dry, protected from light and usually at -20°C, because moisture and oxidation degrade them. Many crystalline steroids are chemically robust solids, but storage requirements vary by compound, so follow the supplier’s data sheet. Solutions of either should be aliquoted and protected from light and repeated freeze-thaw cycles.
Do peptides and steroids need different analytical methods?
Both are routinely analysed by liquid chromatography and mass spectrometry. Peptides absorb UV light at 214–220 nm through their peptide bonds, which suits RP-HPLC detection, whereas many steroids lack a strong chromophore and are often detected by mass spectrometry or after derivatisation. Identity confirmation by accurate mass applies to both classes.
The compounds discussed in this article are supplied for in-vitro laboratory research only and are not for human or veterinary use.